Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich’s Ataxia
Published on January 8, 2025
of Dr. Wilson at the University of Pennsylvania received sponsored research funding from FA212 LLC. Penn owns an equity interest in FA212
Other news